Skip to Content

GS UHL (Votrient pazopanib 400 mg)

Generic Name: pazopanib

Pill with imprint GS UHL is Yellow, Capsule-shape and has been identified as Votrient pazopanib 400 mg. It is supplied by GlaxoSmithKline.

Votrient is used in the treatment of renal cell carcinoma; soft tissue sarcoma and belongs to the drug class VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Votrient pazopanib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GS UHL

Votrient

Generic Name:
pazopanib
Imprint:
GS UHL
Strength:
pazopanib 400 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
GlaxoSmithKline
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide